Microvention AnEurysm & STroke Real-life Data cOllection
NCT ID: NCT06494436
Last Updated: 2025-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
750 participants
OBSERVATIONAL
2024-12-30
2030-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry for Study of Coils in Intracranial Aneurysms
NCT01000675
Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy
NCT06467396
Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
NCT02281721
Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO)
NCT01088672
International Multicenter Registry for Mechanical Recanalization Procedures in Acute Stroke
NCT01399762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
All Microvention Class III implantable device CE marked
Endovascular treatment of ruptured or unruptured intracranial aneurysms with commercially available MicroVention implant devices.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is treated for a ruptured or unruptured intracranial aneurysm using a commercially available MicroVention implant device as the primary treatment device and the decision to use this device has been made by the treating physician outside the context of the MAESTRO-1 study.
Exclusion Criteria
* Patient is participating or intends to participate in another study that changes the site practice.
* Patient has been previously enrolled into the MAESTRO-1 study.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Microvention-Terumo, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alejandro Tomasello, MD
Role: STUDY_CHAIR
University Hospital Vall D'Hebron
Franziska Dorn, Prof.
Role: STUDY_CHAIR
Bonn University Hospital
Sarah Power, MD
Role: STUDY_CHAIR
Beaumont Hospital
Krzysztof Kadziolka, MD
Role: STUDY_CHAIR
John Paul II Independent Public Specialist Western Hospital
Gaultier Marnat, MD
Role: STUDY_CHAIR
Hôpital Pellegrin, CHU de Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Álvaro Cunqueiro Hospital - University Hospital Complex of Vigo, Department of Radiology
Vigo, Pontevedra, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Oscar Vila Nieto, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAESTRO-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.